• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA365 INTRAGASTRIC BALLOON SYSTEM; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA365 INTRAGASTRIC BALLOON SYSTEM; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Model Number B-50012
Device Problems Burst Container or Vessel (1074); Deflation Problem (1149); Use of Device Problem (1670)
Patient Problem Vomiting (2144)
Event Date 12/26/2023
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that an orbera365 intragastric balloon system was used on an intragastric balloon placement procedure performed on march 23, 2023.On december 26, 2023, the patient vomited blue-colored vomit and had green-colored urine.Upon confirmation by an endoscopic procedure, the deflated balloon was explanted.Note: it was reported that methylene blue was used when filling the orbera balloon.However, according to the instructions for use (ifu) the igb is places in the stomach and filled with sterile saline.
 
Manufacturer Narrative
Block a4: patient's start weight: 73 kg.Patient's weight at time of event: 61 kg.Block h6: problem code a0402 is being used to capture the reportable event of balloon burst.Problem code f2202 is being used to capture the reportable event of endoscopic procedure.
 
Event Description
It was reported to boston scientific corporation that an orbera365 intragastric balloon system was used on an intragastric balloon placement procedure performed on (b)(6) 2023.On (b)(6) 2023, the patient vomited blue-colored vomit and had green-colored urine.Upon confirmation by an endoscopic procedure, the deflated balloon was explanted.Note: it was reported that methylene blue was used when filling the orbera balloon.However, according to the instructions for use (ifu) the igb is places in the stomach and filled with sterile saline.
 
Manufacturer Narrative
Block a4: patient's start weight: 73 kg.Patient's weight at time of event: 61 kg.Block h6: problem code a1401 is being used to capture the reportable event of balloon deflated.Problem code f2202 is being used to capture the reportable event of endoscopic procedure.Block h10: investigation summary: with all the available information, boston scientific concludes that the reported event of balloon deflated is confirmed.Device analysis found the balloon was returned deflated with green coloration on the shell.There was a large hole on the shell and the hole had rounded edges and rolled inwards.It was reported that methylene blue was added to the orbera balloon when filling it.However, the orbera365 intragastric balloon system directions for use (ifu) states the igb is placed in the stomach and filled with sterile saline.Balloon deflated is known and documented in the labeling and all reasonable steps have been taken (including both short or long term known complications or adverse reactions).Based on all available information and analysis of the returned device, the most probable cause of this complaint is known inherent risk of device.Device history record review: a review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.Device technical analysis: the orbera365 intragastric balloon system was received for analysis.Visual inspection of the balloon noted the balloon was received deflated with green coloration on the shell and there was a large hole on the shell that had rounded edges and rolled inwards.Labeling review: a labeling review was performed and from the information available, this device was used in a manner inconsistent with the instructions for use (ifu).It was reported that methylene blue was added to the orbera balloon when filling it.However, the orbera365 intragastric balloon system directions for use (ifu) states: the igb is placed in the stomach and filled with sterile saline.Balloon deflated is known and documented in the labeling and all reasonable steps have been taken (including both short or long term known complications or adverse reactions).Investigation conclusion: based on all available information and analysis of the returned device, the most probable root cause of this complaint is known inherent risk of device.Block h11: block h6 imdrf code a0402 has been corrected to imdrf code a1401 to capture the reportable event of balloon deflated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA365 INTRAGASTRIC BALLOON SYSTEM
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s. capital of texas hwy
bldg 1 suite 300
austin TX 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA S.R.L
alajuela, 02
CS  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18545072
MDR Text Key333268059
Report Number3005099803-2023-07189
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeSA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberB-50012
Device Lot NumberAF05275
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/27/2023
Initial Date FDA Received01/19/2024
Supplement Dates Manufacturer Received03/20/2024
Supplement Dates FDA Received04/15/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/30/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
Patient Weight61 KG
-
-